Department of Orthopedics, Tianjin NanKai Hospital, Tianjin, 300100, China.
Department of Network Security and Informatization, Tianjin Medical University, Tianjin, 300070, China.
BMC Geriatr. 2023 Mar 4;23(1):122. doi: 10.1186/s12877-023-03854-w.
Constipation was associated with incidence of dementia and cognitive decline. Laxatives are the mainstay of constipation management and are commonly used among older populations for both treatment and prevention of constipation. However, the association between use of laxatives and incident dementia, and whether laxatives use may modify the effect of genetic predisposition on dementia remains unclear.
We applied 1:3 propensity score matching to balance the baseline characteristics of the laxative users versus non-users and to reduce potential confounders using multi-variates adjusted Cox hazards regression models. We categorized genetic risk into three groups (low, middle, and high) through a genetic risk score of common genetic variants. Information on laxatives use was assessed at baseline and categories into four varieties, including bulk forming laxatives, softeners and emollients, osmotic laxatives, and stimulant laxatives.
Of 486,994 participants, there were 14,422 laxatives users in UK Biobank. After propensity score matching, participants with use of laxatives (n = 14,422) and matched non-laxative (n = 43,266) exposed individuals were enrolled. Over follow-up to 15 years, there were 1377 participants developed dementia (539 for Alzheimer's disease, and 343 for vascular dementia). The use of laxatives had greater risk of dementia (HR, 1.72; 95% CI:1.54-1.92), Alzheimer's disease (HR, 1.36; 95% CI: 1.13-1.63), and vascular dementia (HR, 1.53; 95% CI: 1.23-1.92). Compared to non-laxative exposed participants, those with use of softeners and emollients drugs, stimulant laxatives, and osmotic laxatives were associated with 96% (HR, 1.96; 95 CI: 1.23-3.12; P = 0.005), 80% (HR, 1.80; 95% CI: 1.37-2.37; P < 0.001), and 107% (HR, 2.07; 95% CI: 1.47-2.92; P < 0.001) higher risk of developed incident dementia, respectively. In joint effect analysis, compared to participants with low/middle genetic susceptibility and non-laxatives use, the HR (95% CIs) of dementia was 4.10 (3.49-4.81) for those with high genetic susceptibility plus use of laxatives. There was an additive interaction between laxatives use and genetic susceptibility on dementia (RERI: 0.736, 95% CI: 0.127 to 1.246; AP: 0.180, 95% CI: 0.047 to 0.312).
Use of laxatives was associated with higher risk of dementia and modify the effect of genetic susceptibility on dementia. Our findings suggested that attention should be paid to the relationship between laxatives use and dementia, especially in people at high genetic susceptibility.
便秘与痴呆和认知能力下降的发生率有关。泻药是便秘管理的主要方法,在老年人中常用于治疗和预防便秘。然而,使用泻药与痴呆的发生之间的关系,以及泻药的使用是否可以改变遗传易感性对痴呆的影响尚不清楚。
我们应用 1:3 的倾向评分匹配来平衡泻药使用者和非使用者的基线特征,并使用多变量调整的 Cox 风险回归模型来减少潜在的混杂因素。我们通过常见遗传变异的遗传风险评分将遗传风险分为低、中、高三个组。泻药使用信息在基线时进行评估,并分为四种类型,包括容积形成性泻药、软化剂和润滑剂、渗透性泻药和刺激性泻药。
在 UK Biobank 中,有 486994 名参与者,其中有 14422 名使用了泻药。经过倾向评分匹配后,招募了使用泻药(n=14422)和匹配的非泻药(n=43266)暴露个体。在 15 年的随访中,有 1377 名参与者发展为痴呆症(539 名患有阿尔茨海默病,343 名患有血管性痴呆症)。使用泻药与痴呆(HR,1.72;95%CI:1.54-1.92)、阿尔茨海默病(HR,1.36;95%CI:1.13-1.63)和血管性痴呆(HR,1.53;95%CI:1.23-1.92)的风险增加有关。与非泻药暴露参与者相比,使用软便剂和润滑剂药物、刺激性泻药和渗透性泻药与痴呆症发生风险分别增加了 96%(HR,1.96;95%CI:1.23-3.12;P=0.005)、80%(HR,1.80;95%CI:1.37-2.37;P<0.001)和 107%(HR,2.07;95%CI:1.47-2.92;P<0.001)。在联合效应分析中,与低/中遗传易感性和非泻药使用者相比,高遗传易感性加上泻药使用者的痴呆症 HR(95%CI)为 4.10(3.49-4.81)。泻药使用和遗传易感性对痴呆症之间存在附加交互作用(RERI:0.736,95%CI:0.127 至 1.246;AP:0.180,95%CI:0.047 至 0.312)。
使用泻药与痴呆风险增加有关,并改变了遗传易感性对痴呆的影响。我们的研究结果表明,应该注意泻药使用与痴呆之间的关系,特别是在遗传易感性高的人群中。